口服抗癌药物的简短患者报告结果测量:多中心观察性研究
Emily Mackler1,2, Taylor Weis1, Kelly Romo2
1College of Pharmacy, University of Michigan, 1007 E Huron St., Ann Arbor, MI, 48104-1628, United States, 1 7347635150.
JMIR formative research
|February 18, 2026
概括
对口服抗癌药物的快速患者报告结果测量 (RapidPRO) 发现了频繁的症状和28%的不遵守. 该工具有助于诊所识别需要在症状管理和药物服药方面得到支持的患者.
科学领域:
- 在瘤学瘤学.
- 患者报告的结果
- 药理学 药理学是指药理学的学科.
背景情况:
- 密歇根瘤质量联盟开发了RapidPRO,这是一个患者报告的口服抗癌剂 (OAAs) 结果指标.
- 目标是为所有OAA创建一个单一的工具,以简化临床实践中的实施.
- 这与常见的癌症特异性方法形成鲜明对比.
研究的目的:
- 描述RapidPRO在瘤实践中的临床用途.
- 量化症状负担,患者对症状管理的信心,以及OAA药物坚持.
- 评估RapidPRO在捕获OAAs患者体验方面的实用性.
主要方法:
- 从2016年7月到2018年12月,在6个瘤实践中进行了一项观察性研究.
- 使用RapidPRO来评估患者的症状,信心和OAA药物坚持.
- 分析了695名患者完成的2252次RapidPRO的数据.
主要成果:
- 超过一半 (53.9%) 完成的RapidPRO报告至少有一个中度至重度症状.
- 在28%的患者中报告了药物不服药.
- 不坚持最常见的原因是出现副作用;46.5%的患者报告了最烦人的症状.
结论:
- 该RapidPRO措施有效地捕捉了OAAs患者的症状负担和药物不服药.
- 实施RapidPRO使实践能够识别出现显著症状或不坚持的患者.
- 这有助于及时进行干预,以改善患者护理和治疗结果.
相关概念视频
Bioavailability Study Design: Healthy Subjects Versus Patients
165
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
165
Assessment of the Mouth
1.2K
A thorough mouth assessment, including inspection and palpation of the lips, gums, tongue, tonsils, uvula, and pharynx, is crucial in detecting potential health issues. Diseases ranging from oral cancer to systemic conditions like diabetes could be identified early through careful oral examination. This article provides a detailed guide on conducting a comprehensive mouth assessment.
Mouth Inspection
The inspection begins with visually examining the mouth for symmetry, color, and size.
Mouth Inspection
The inspection begins with visually examining the mouth for symmetry, color, and size.
1.2K
Cancer Survival Analysis
788
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
788


